Services

New Product Planning

Target Product Profile Development and Integrated Development Planning: Aligning clinical, regulatory, and commercial strategies to create a unified roadmap for product success.
Market Opportunity Assessment: Identifying unmet needs and market dynamics to strategically position your asset for maximum impact.
Asset Leadership : Guiding the development of a differentiated product vision that drives alignment across cross-functional teams.

Portfolio Prioritisation and Resource Allocation: Identifying high-value assets and optimising investments to balance risk and maximise ROI.
Scenario Planning and Go/No-Go Decisions: Evaluating market scenarios and asset potential to guide critical investment and pipeline decisions.
Value Inflection Mapping: Aligning strategies with key milestones to unlock value and support impactful decision-making.

Tailored Market Access Strategies: Designing integrated plans for the US and EU, addressing pricing, reimbursement, and payer dynamics, with a focus on emerging trends like digital health and personalised medicine
Navigating Evolving Payer Policies: Including guiding clients through joint clinical assessments and adapting to the new EU HTA framework to secure optimal market access
Value Proposition: Crafting compelling value stories and engaging early with payers to align expectations and minimise barriers